KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Moderna (MRNA) over the last 6 years, with Sep 2025 value amounting to $390.0 million.

  • Moderna's Shares Outstanding (Diluted Average) fell 2.26% to $390.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $390.0 million, marking a year-over-year decrease of 2.26%. This contributed to the annual value of $384.0 million for FY2024, which is 0.52% up from last year.
  • Latest data reveals that Moderna reported Shares Outstanding (Diluted Average) of $390.0 million as of Q3 2025, which was up 0.52% from $388.0 million recorded in Q2 2025.
  • Moderna's Shares Outstanding (Diluted Average)'s 5-year high stood at $434.0 million during Q3 2021, with a 5-year trough of $382.0 million in Q3 2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $387.7 million, with a median of $384.0 million in 2024.
  • In the last 5 years, Moderna's Shares Outstanding (Diluted Average) increased by 21.81% in 2021 and then declined by 9.46% in 2023.
  • Over the past 5 years, Moderna's Shares Outstanding (Diluted Average) (Quarterly) stood at $431.0 million in 2021, then fell by 3.48% to $416.0 million in 2022, then declined by 8.17% to $382.0 million in 2023, then rose by 0.52% to $384.0 million in 2024, then dropped by 2.26% to $390.0 million in 2025.
  • Its last three reported values are $390.0 million in Q3 2025, $388.0 million for Q2 2025, and $386.0 million during Q1 2025.